Chimeric antibodies, as well as fusion proteins which comprise chimeric antibodies, are disclosed. The antibodies bind to GM-CSF, CD-30, and G250 antigen. The fusion proteins include biologically active portions of tumor necrosis factor, or full length tumor necrosis factor. Expression vectors adapted for production of the antibodies, as well as methods for manufacturing these, are also disclosed.

 
Web www.patentalert.com

< Triamide-substituted heterobicyclic compounds

> Method for the identification of molecules and biomarkers using chemical, biochemical and biological data

~ 00438